Healthcare costs and outcomes associated with laboratory-confirmed Lyme disease in Ontario, Canada: A population-based cohort study
Title | Healthcare costs and outcomes associated with laboratory-confirmed Lyme disease in Ontario, Canada: A population-based cohort study |
Publication Type | Journal Article |
Year of Publication | 2023 |
Journal | PLoS One |
Volume | 18 |
Issue | 6 |
Start Page | e0286552 |
Date Published | 06/2023 |
Authors | Mac S, Evans G, Pullenayegum EM, Patel SN, Sander B |
Abstract | A total of 2,808 cases were identified with a mean age of 46.5 (20.7) years and 44% female. Within 30-days, 404 (14.3%) cases required an ED visit and 63 (2.4%) cases required hospitalization. The mean (95% CI) total costs for LD cases in pre-diagnosis, acute, and post-acute care phases were $209 ($181, 238), $1,084 ($956, $1,212), and $1,714 ($1,499, $1,927), respectively. The highest mean attributable 10-day cost was $275 ($231, $319) during acute care. At 1-year post-infection, LD increased the relative risk of nerve palsies by 62 (20, 197), and polyneuropathy by 24 (3.0, 190). LD resulted in 16 Lyme meningitis events vs. 0 events in the unexposed. |
URL | https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0286552 |